Newsroom
Our latest developments
Orca Bio’s announcements and press releases
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
ViewOrca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
ViewOrca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
ViewOrca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
ViewOrca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ViewOrca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
ViewOrca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting
View